Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Gerontology|August 20, 2009
Calorie restriction and dwarf mice in gerontological researchJ McKee Alderman, Michael A DePetrillo, Angela M Gluesenkamp, et al.
Biochimica Et Biophysica Acta|June 5, 2008
Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid compositionTal M Lewin, Hendrik de Jong, Nicole J M Schwerbrock, et al.
Nature Medicine|June 21, 2005
Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophyUtpal B Pajvani, Maria E Trujillo, Terry P Combs, et al.
The Journal of Biological Chemistry|December 24, 2002
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivityUtpal B Pajvani, Xueliang Du, Terry P Combs, et al.
The American Journal of Pathology|May 22, 2003
Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuliScott E Woodman, Anthony W Ashton, William Schubert, et al.
Journal of the Endocrine Society|December 22, 2017
Plasma Amino Acids vs Conventional Predictors of Insulin Resistance Measured by the Hyperinsulinemic ClampCherise C Labonte, Samaneh Farsijani, Errol B Marliss, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2015
Adiponectin-SOGA Dissociation in Type 1 DiabetesTerry P Combs, Janet K Snell-Bergeon, David M Maahs, et al.
Diabetes|January 24, 2003
Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectinTerry P Combs, Anders H Berg, Michael W Rajala, et al.
The Journal of Biological Chemistry|December 12, 2001
Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalitiesBabak Razani, Terry P Combs, Xiao Bo Wang, et al.
Hepatology (Baltimore, Md.)|June 4, 2009
Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathwayCarl F Raetzsch, Natasha L Brooks, J McKee Alderman, et al.
Pageof 4